Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Targeted drugs a chance for a better cureBergh, Jonas ; Jonsson, BertilLäkartidningen, 2010-04, Vol.107 (16), p.1071-1074 [Periódico revisado por pares]SwedenTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Denosumab efficient against osteoporosis. A biological drug gives new possibilities to treat a public diseaseTörring, OveLäkartidningen, 2010-03, Vol.107 (9), p.574-575 [Periódico revisado por pares]SwedenTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Utilization of antineoplastic agents in Sweden and EuropeWilking, Nils ; Jönsson, Bengt ; Björn, WettermarkLäkartidningen, 2010-04, Vol.107 (16), p.1075-1080 [Periódico revisado por pares]SwedenTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
New analgesics coming. Monoclonal NGF antibody takes the leadClaesson, AlfLäkartidningen, 2009-02, Vol.106 (7), p.430-434 [Periódico revisado por pares]SwedenTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Current drug therapy in Crohn disease--national guidelinesAlmer, Sven ; Befrits, Ragnar ; Eriksson, Anders S ; Halfvarson, Jonas ; Hindorf, Ulf ; Löfberg, RobertLäkartidningen, 2009-11, Vol.106 (45), p.2988-2993 [Periódico revisado por pares]SwedenTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Management of severe attack of ulcerative colitisTysk, Curt ; Almer, Sven ; Andersson, Magnus V ; Befrits, Ragnar ; Hertervig, Erik ; Kilander, Anders ; Lindgren, Stefan ; Suhr, OleLäkartidningen, 2009, Vol.106 (45), p.2994-2998 [Periódico revisado por pares]SwedenTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Promising treatment of neovascular age-related macular degeneration is coming. But to what price?Frennesson, ChristinaLäkartidningen, 2007-02, Vol.104 (7), p.486-487 [Periódico revisado por pares]SwedenTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Biological drugs in inflammatory bowel disease. Valuable supplement--but only when conventional therapy is not sufficientHellström, Per M ; Schmidt, Daniel ; Karlén, PerLäkartidningen, 2007-10, Vol.104 (41), p.2973-2976 [Periódico revisado por pares]SwedenTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Prophylaxis against RS virus infectionNavér, Lars ; Eriksson, Margareta ; Ewald, Uwe ; Linde, Annika ; Lindroth, Magnus ; Schollin, JensLäkartidningen, 2002-01, Vol.99 (3), p.170-171 [Periódico revisado por pares]SwedenTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLCAntonia, Scott J ; Villegas, Augusto ; Daniel, Davey ; Vicente, David ; Murakami, Shuji ; Hui, Rina ; Kurata, Takayasu ; Chiappori, Alberto ; Lee, Ki H ; de Wit, Maike ; Cho, Byoung C ; Bourhaba, Maryam ; Quantin, Xavier ; Tokito, Takaaki ; Mekhail, Tarek ; Planchard, David ; Kim, Young-Chul ; Karapetis, Christos S ; Hiret, Sandrine ; Ostoros, Gyula ; Kubota, Kaoru ; Gray, Jhanelle E ; Paz-Ares, Luis ; de Castro Carpeño, Javier ; Faivre-Finn, Corinne ; Reck, Martin ; Vansteenkiste, Johan ; Spigel, David R ; Wadsworth, Catherine ; Melillo, Giovanni ; Taboada, Maria ; Dennis, Phillip A ; Özgüroğlu, MustafaThe New England journal of medicine, 2018-12, Vol.379 (24), p.2342-2350 [Periódico revisado por pares]United States: Massachusetts Medical SocietyTexto completo disponível |